Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Dec 20, 2022 8:04pm
188 Views
Post# 35183591

RE:RE:RE:RE:RE:RE:RE:RE:i-Dialco

RE:RE:RE:RE:RE:RE:RE:RE:i-Dialco Ha. I can't help much with BSW as I posted that I put him on "ignore" back in Oct. adding:  "Can't you see that the whole premise for you bash and your credibility just crumble with your obvious lies?"

On EMH.. the Share Price doesn't reflect known information- it reflects Spectral's management.

It reflects their inability to ever start the DIMI trial, or to enroll promised numbers into the Tigris trial, It reflects Seto being more than 1 yr off on reaching 60% (and counting), it reflects their lack of transparency- like in the Baxter deal- or even Baxter being part of the financing.. it reflects the witholding of who "confirmed partner #2" was, or that they had not fulfilled the Infomed contract back in June..

At present, management is fine with their only analyst and shareholders believing their Dialco investments are now worth zero. 

So when you look at that track record I'd say .33 is probably fair. Our science is solid and should be worth many dollars- but the way Seto and Co. are running the show makes it high risk. As their loss of control of Dialco has just shown us.





<< Previous
Bullboard Posts
Next >>